Candida Infection Clinical Trial
Official title:
Kinetics of Serum β-D-glucan During Peritonitis With Candida in Resuscitation
Intraabdominal fungal infections with Candida are constantly increasing. Their diagnosis and treatment is difficult. Morbidity and mortality are high. Β-D-Glucan has been proposed as a marker of systemic fungal infection in candidemia. Moreover, its kinetics is associated with therapeutic success. On the other hand, there are no data on intraabdominal infections that are much more frequent. The objective of the study is to evaluate the initial levels of β-D-glucan and its daily kinetics during the treatment of fungal peritonitis in resuscitation compared to a control group with a yeast-free peritonitis.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03641131 -
Ampholipad Real-World Data in Taiwan
|
||
Completed |
NCT03203551 -
Clinical and Laboratorial Evaluation of the Desinfection Solutions in Candida Species From Total Prostheses and Palate of Total Edentulous.
|
N/A | |
Not yet recruiting |
NCT03666195 -
The Anti-microbial Effect of Titanium Dioxide Nano Particles in Complete Dentures Made for Edentulous Patients
|
N/A | |
Active, not recruiting |
NCT06146504 -
Clinical Study to Evaluate the Efficacy of an Anti-Fungal Supplement
|
N/A | |
Completed |
NCT01495039 -
Antifungal Prophylaxis in Intensive Care Unit (ICU) Patients
|
Phase 4 | |
Completed |
NCT04935463 -
Mucormycosis in COVID-19
|
||
Completed |
NCT05720728 -
Research of New Serological Markers for the Diagnosis and Monitoring of Candidaemia in Hospitalized Patients
|
||
Completed |
NCT01743690 -
The Use of Probiotics in Patients With Symptomatic Oral Lichen Planus
|
N/A | |
Completed |
NCT03630770 -
Effect of Medium Chain Triglyceride Intake on Colonization of Preterm Infants With Candida
|
Phase 1 | |
Recruiting |
NCT05908682 -
Safety of Pregnant Subjects Exposed to Ibrexafungerp Including Infant Outcomes
|
||
Not yet recruiting |
NCT05761197 -
Oropharyngeal Candidiasis (OPC) and S-ECC
|
||
Recruiting |
NCT05225493 -
HIV Indicator Diseases in Hospital and Primary Care
|
||
Completed |
NCT04148287 -
An Open-label Study of APX001 for Treatment of Patients With Candidemia/Invasive Candidiasis Caused by Candida Auris
|
Phase 2 |